Literature DB >> 6322831

The peroxidase activity and cellular content of granule proteins in PMN during pregnancy.

G Oberg, G Lindmark, L Moberg, P Venge.   

Abstract

The cellular content of myeloperoxidase (MPO), chymotrypsin-like cationic protein (CCP) and lactoferrin (LF) of isolated polymorphonuclear leucocytes (PMNs) from pregnant women were analysed by immuno-chemical methods. The cellular levels of MPO and CCP were unaltered during pregnancy while the cellular levels of LF were increased during pregnancy and post partum (P less than 0.01). Peroxidase activity within isolated PMN was analysed by two methods, a Guaiacol method and a Chemiluminescence method. The activity was found to be reduced during pregnancy. The reduction was explained by the reduction in eosinophil peroxidase which in turn was a consequence of a reduced number of circulating eosinophils during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6322831     DOI: 10.1111/j.1365-2141.1983.tb02853.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Molecular forms of myeloperoxidase in human plasma.

Authors:  R L Olsen; T K Steigen; T Holm; C Little
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

2.  Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.

Authors:  M Carlson; Y Raab; L Sevéus; S Xu; R Hällgren; P Venge
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children.

Authors:  M Bondestam; K Funa; P Venge; G V Alm
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Bactericidal proteins and neutral proteases in diabetes neutrophils.

Authors:  G Oberg; R Hällgren; L Moberg; P Venge
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.